Overview

Intensity-modulated Radiation Therapy Combined With Cisplatin or Nedaplatin Chemotherapy in Nasopharyngeal Carcinoma

Status:
Unknown status

Trial end date:
2017-12-01

Target enrollment:

Participant gender:

Summary

This phase II trial is studying cisplatin or nedaplatin combine with IMRT to evaluate which one is better efficacy and security in nasopharyngeal carcinoma.

Phase:

Phase 2

Details

Lead Sponsor:

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

Treatments:

Cisplatin
Nedaplatin